Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma. (Record no. 28403847)

MARC details
000 -LEADER
fixed length control field 00843 a2200229 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517215309.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field ####s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2162-3619
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1186/s40164-018-0103-z
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Johnston, Patrick B
245 00 - TITLE STATEMENT
Title Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Experimental hematology & oncology
Date of publication, distribution, etc. 2018
300 ## - PHYSICAL DESCRIPTION
Extent 12 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pinter-Brown, Lauren C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Warsi, Ghulam
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name White, Kristen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ramchandren, Radhakrishnan
773 0# - HOST ITEM ENTRY
Title Experimental hematology & oncology
Related parts vol. 7
-- p. 12
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1186/s40164-018-0103-z">https://doi.org/10.1186/s40164-018-0103-z</a>
Public note Available from publisher's website

No items available.